102
PATHOLOGY

PATHOLOGY

Embed Size (px)

DESCRIPTION

Chronic Inflammation. PATHOLOGY. Chronic Inflammation. Chronic inflammation may occur : either as a sequel to acute inflammation (acute inflammation chronic inflammation) , or as a primary immune response to a foreign antigen (usually viral). Inflammation. - PowerPoint PPT Presentation

Citation preview

Page 1: PATHOLOGY

PATHOLOGY

Page 2: PATHOLOGY

Chronic Inflammation

Chronic inflammation may occur: • either as a sequel to acute inflammation

(acute inflammationchronic inflammation), or

• as a primary immune response to a foreign antigen (usually viral).

Page 3: PATHOLOGY

Inflammation

Inciting Inciting

StimulusStimulus

AcuteAcute

InflammationInflammation

Chronic-active Chronic-active

Inflammation Inflammation

Chronic

Inflammation

ResolutionResolution (no scar) (no scar)

AbscessAbscess Resolution with

scarring**The longer the stimulus

persists, the greater the

scarring will be.

A dynamic contunium of change

Organization (exudatescar *)

Page 4: PATHOLOGY

Chronic inflammation is considered to be inflammation of prolonged duration (weeks or months) in which active inflammation, tissue destruction, and attempts at healing are proceeding simultaneously.

It may follow acute inflammation, as described earlier, chronic inflammation frequently begins insidiously, as a low-grade, flaming, often asymptomatic response.

Page 5: PATHOLOGY

Etiology of Chronic Inflammation Persistent infections by certain

microorganismsMycobacteriumTreponema pallidumcertain fungi.

Prolonged exposure to potentially toxic agents, either exogenous or endogenous (silicosis)

Autoimmune diseases

Page 6: PATHOLOGY

Chronic inflammation is characterized by:

(1) infiltration with mononuclear cells, which include macrophages, lymphocytes, and plasma cells, a reflection of a persistent reaction to injury,

(2) tissue destruction, largely induced by the inflammatory cells,

(3) attempts at repair by connective tissue replacement, namely proliferation of fibroblasts, in particular, fibrosis.

Page 7: PATHOLOGY

FIBROSIS

There are four components to this process:

1. Formation of new blood vessels (angiogenesis)

2. Migration and proliferation of fibroblasts

3. Deposition of extracellular matrix

4. Maturation and organization of the fibrous tissue

Page 8: PATHOLOGY

Fibrosis after chronic bronchitis.

Page 9: PATHOLOGY

Scarring after chronic inflammation-Lung

Page 10: PATHOLOGY

InflammationChronic Inflammation – Syphilis

Lymphocytic chronic inflammatory infiltrate in the wall of the aorta in syphilitic aortitis.

Page 11: PATHOLOGY

InflammationChronic Inflammation Histologic features

Mononuclear cells – macrophages, lymphocytes, and plasma cells

Tissue destruction by ongoing inflammation, thought to be due to cytokines produced locally by

the mononuclear cells

Attempts at healing, including fibroblasts and fibrosis.

Page 12: PATHOLOGY
Page 13: PATHOLOGY

InflammationChronic Inflammation Monocyte/Macrophages They are components of the mononuclear phagocyte

system (MPS), previously known as the reticuloendothelial system (RES). • Key cell in chronic and granulomatous inflammation• Reproduce locally, at the site of injury• Produce numerous cytokines, which continue to

recruit additional cells, including more macrophages• May present antigen to T-cells, producing specific

hypersensitivity reactions

Page 14: PATHOLOGY

The MPS consists of closely related cells of bone marrow origin, including blood monocytes, and tissue macrophages.

The latter are diffusely scattered in the connective tissue or clustered in organs such as the liver (Kupffer’s cells), spleen and lymph nodes (sinus histiocytes), and lungs (alveolar macrophages).

Page 15: PATHOLOGY

Blood monocytes begin to emigrate early in acute inflammation, and within 48 hours predominant cell type.

Extravasation of monocytes is governed by the same factors involved in neutrophil emigration, namely adhesion molecules and chemical mediators with chemotactic and activating properties.

When the monocyte reaches the extravascular tissue it undergoes transformation into a larger phagocytic cell, the macrophage.

In addition to performing phagocytosis, macrophages have the potential of being “activated,” a process that results in an increase in cell size, increased levels of lysosomal enzymes, more active metabolism, and greater ability to phagocytose and kill ingested microbes.

Page 16: PATHOLOGY

Activation signals include cytokines (e.g., IFN-g) secreted by sensitized T lymphocytes, bacterial endotoxins, other chemical mediators, and ECM proteins like fibronectin.

Following activation, the macrophages secrete a wide variety of biologically active products that are important mediators of the tissue destruction, vascular proliferation, and fibrosis characteristic of chronic inflammation

Page 17: PATHOLOGY
Page 18: PATHOLOGY

In chronic inflammation macrophage accumulation persists, mediated by different mechanisms, each predominating in different types of reactions:

1. Continued recruitment of monocytes from the circulation, which results from the steady expression of adhesion molecules and chemotactic factors. (most important source for macrophages) Chemotactic stimuli for monocytes C5a; cytokines of the IL-8 family (chemokines) produced by activated macrophages and lymphocytes (MCP-1 for monocytes); certain growth factors (PDGF and TGF-b); fragments from the break-down of collagen, fibronectin and fibrinopeptides.

2. Local proliferation of macrophages after their emigration from the bloodstream.

3. Immobilization of macrophages within the site of inflammation. Indeed, certain cytokines (macrophage inhibitory factor) and

oxidized lipids can cause such immobilization

Page 19: PATHOLOGY

Lymphocytes: Lymphocytes are mobilized in both antibody- and cell-mediated immune reactions and also, for reasons unknown, in non-immune

mediated inflammation. Lymphocytes of different types (T, B) or states (naive,

activated or memory T cell) use various adhesion molecules (VLA-4/VCAM-1 and ICAM-1/ LFA-1 predominantly) and chemical mediators (largely cytokines) to migrate into inflammatory sites.

Lymphocytes can be activated by contact with antigen. Activated lymphocytes produce cytokines (formerly called as: “lymphokines”), and one of these, IFN-g is a major stimulator of monocytes and macrophages.

Page 20: PATHOLOGY
Page 21: PATHOLOGY

Plasma cells: They produce antibody directed either against persistent antigen in the inflammatory site or against altered tissue components.

Eosinophils: They are characteristic of immune reactions mediated by IgE and of parasitic infections.

Like neutrophils, they use adhesion molecules and chemotactic agents (derived from mast cells, lymphocytes, or macrophages) to exit the blood.

Eosinophils are phagocytic and undergo activation. Their granules contain major basic protein (MBP), a highly

cationic protein that is toxic to parasites but also causes lysis of mammalian epithelial cells. They may thus be of benefit in parasitic infections but contribute to tissue damage in immune reactions.

Page 22: PATHOLOGY

Plasma cells

Page 23: PATHOLOGY

Types of Chronic Inflammation

1. Non-granulomatous Chronic Inflammation

a) Chronic viral infections b) Chronic autoimmune diseasesc) Chronic chemical intoxicationsd) Chronic nonviral infectionse) Allergic inflammation and metazoal

infections,2. Granulomatous Chronic

Inflammation

Page 24: PATHOLOGY

Non-granulomatous Chronic Inflammation

Characterized by the accumulation of sensitized lymphocytes (specifically activated by antigen), plasma cells, and macrophages in the injured area.

These cells are scattered diffusely throughout the tissue, however, and do not form granulomas.

Scattered tissue necrosis and fibrosis are common.

Page 25: PATHOLOGY

Classification of non-granulomatous chronic inflammation:

a) Chronic viral infections

b) Chronic autoimmune diseases

c) Chronic chemical intoxications

d) Chronic nonviral infections

e) Allergic inflammation and metazoal infections

Page 26: PATHOLOGY

a) Chronic viral infections: Persistent infection of parenchymal cells by viruses main components are a B cell response and a T cell

cytotoxic response. The affected tissue shows accumulation of

lymphocytes and plasma cells that produce cytotoxic effects on the cell containing the viral antigen, causing cell necrosis.

This cytotoxic effect is mediated either by killer T lymphocytes or by cytotoxic antibody acting with complement.

Ongoing parenchymal cell necrosis is associated with repair characterized by fibroblast proliferation and deposition of collagen.

Page 27: PATHOLOGY

b) Chronic autoimmune diseases: immune response mediated by cytotoxic

antibody and killer T cells occurs in several autoimmune diseases.

The antigen involved is a host cell molecule that is perceived as foreign by the immune system.

The pathologic result is similar to the non-granulomatous chronic inflammation seen in chronic viral infections, with cell necrosis, fibrosis, and lymphocytic and plasma cell infiltration of the tissue.

Page 28: PATHOLOGY

c) Chronic chemical intoxications: Persistent toxic substances such as alcohol

produce chronic inflammation, notably in the pancreas and liver.

The toxic substance is not antigenic, but by causing cell necrosis it may result in alteration of host molecules so that they become antigenic and evoke an immune response.

The features of cell necrosis and repair by fibrosis in such cases dominate the features of the immune response.

In many cases of alcoholic chronic pancreatitis, the lymphocytic and plasma cell infiltration is slight.

Page 29: PATHOLOGY

d) Chronic nonviral infections: specific type of non-granulomatous chronic inflammation is

seen with certain microorganisms; (i) survive and multiply in the cytoplasm of macrophages

after direct phagocytosis (ii) evoke a very ineffective T cell response. accumulation of large numbers of foamy macrophages in

the tissue. The macrophages are present diffusely in the tissue without aggregating into granulomas.

The ability of the macrophage to kill the organism is limited because of the poor T cell response, permitting the organisms to multiply in the cell.

large numbers of organisms are present in the cytoplasm of the macrophages. The main defense appears to be direct phagocytosis by the macrophages. Variable numbers of plasma cells and lymphocytes may be present.

Accumulation of infected macrophages in the tissue causes nodular thickening of the affected tissue, a clinical feature that is typical of this type of chronic inflammation.

Page 30: PATHOLOGY

e) Allergic inflammation and metazoal infections: Eosinophils are present in acute hypersensitivity

reactions and accumulate in large numbers in tissues subject to chronic or repeated allergic reactions.

Eosinophils may have evolved as a defense against infection with various metazoal parasites.

Eosinophils respond chemotactically to complement C5a and factors released by mast cells and in turn release a variety of enzymes and basic proteins.

Eosinophils bear high-affinity Fc receptors for IgA and low-affinity receptors for IgE.

Eosinophils are derived from a bone marrow precursor in common with mast cells and basophils,

play a role in modulating histamine release or histamine catabolism.

Mast cells and basophils have high-affinity Fc receptors for IgE.

Page 31: PATHOLOGY

This is a distinctive pattern of chronic inflammatory reaction in which the predominant cell type is an activated macrophage with a modified epithelial-like appearance (epithelioid cells) .

Chronic Granulomatous Inflammation

Page 32: PATHOLOGY

Granuloma: aggregation of macrophages that are transformed into epitheloid cells surrounded by a collar of mononuclear leukocytes, principally lymphocytes and occasionally plasma cells .

The cells in a granuloma are:macrophages and/or histiocytes (principal), lymphocytes (principal), fibroblasts, giant cells.

Page 33: PATHOLOGY

• A cellular mechanism for dealing with indigestible substances

• The principal cells involved in granulomatous inflammation are macrophages and lymphocytes

• Epithelioid histiocytes are the hallmark of granulomatous inflammation

Page 34: PATHOLOGY

A granuloma is an abnormal structure built from at least two activated macrophages adhering to one another.

Such macrophages are called epithelioid cells.

Epithelioid cells have abundant pink cytoplasm, indistinct borders, elongated, euchromatin-rich, reticulated

nuclei.

Page 35: PATHOLOGY

There are two types of granulomas:Foreign body granulomas incited by

relatively inert foreign bodies. Immune granulomas Two factors

determine the formation of immune granulomas:

The presence of indigestible particles of organisms (e.g., the tubercle bacillus)

T cell-mediated immunity to the inciting agent.

Page 36: PATHOLOGY

Granulomas with suppuration With pus in their centers, stellate microabscesses. Bacterial diseases with a propensity to involve

lymph nodes: lymphogranuloma venereum, cat scratch fever, brucellosis, plague, tularemia, glanders-melioidosis, listeria, camphylobacter, yersinia infection.

Page 37: PATHOLOGY

Granulomas with caseation necrosis

Typical of certain fungal and mycobacterial infections: histoplasmosis, blastomycosis, coccidioidomycosis, tuberculosis, leprosy,atypical mycobacteria.

Page 38: PATHOLOGY

Granulomas can contain syncytial giant cells (polykaryons):

Langhans giant cells (in the necrotizing granulomas: tuberculosis) nuclei arranged in a horseshoe around the edge

Foreign body giant cells (in the non-necrotizing granulomas: foreign body granuloma) with nuclei dispersed more or less evenly

Asteroid bodies (in the non-necrotizing granulomas: foreign body granuloma, sarcoidosis) altered cytoskeletal components in the shapes of stars

Schaumann bodies (in the non-necrotizing granulomas: sarcoidosis) laminated calcified nuggets; "conchoid bodies“.

Page 39: PATHOLOGY
Page 40: PATHOLOGY
Page 41: PATHOLOGY

Granulomatous Inflammation

• Immunity may be judged by its effect on the invading organism, but an adverse effect on the host is generally termed hypersensitivity.

• Destruction of tissue is primarily via the action of killer T cells (CD8+), directed by macrophages.

• Products of activated T lymphocytes are important in transforming macrophages into epitheloid cells and multinucleated giant cells.

Page 42: PATHOLOGY

Granulomatous diseases***

Mycobacterial infections: tuberculosis leprosy

Fungal diseases Sarcoidosis Lymphogranuloma

inguinale Foreign body

granuloma

Chronic granulomatous disease

Crohn’s disease Leishmaniasis cutis Berylliosis Brucellosis Syphilis

Page 43: PATHOLOGY

InflammationGranulomatous Inflammation

Caseating Granuloma Non-caseating Granuloma

Caseous NecrosisCaseous Necrosis

Macrophages, Epithelioid Cells, and Giant Cells

Lymphocytes

Fibroblasts

Page 44: PATHOLOGY
Page 45: PATHOLOGY
Page 46: PATHOLOGY
Page 47: PATHOLOGY
Page 48: PATHOLOGY

Langhans giant cells

Page 49: PATHOLOGY

Asteroid bodies

Page 50: PATHOLOGY

Schaumann bodies

Page 51: PATHOLOGY
Page 52: PATHOLOGY
Page 53: PATHOLOGY

InflammationGranulomatous Inflammation

Tuberculous lung, showing massive destruction by granulomatous inflammation.

This type of response is simply the best the body can do, since the inciting organism cannot be removed.

Mycobacteria may live for years, perhaps even a lifetime, within granulomas.

Page 54: PATHOLOGY

FUNCTION & RESULT OF CHRONIC INFLAMMATION

Chronic inflammation serves to contain and remove an injurious agent that is not easily eradicated by the body. Containment and destruction of the agent are largely dependent on immunologic reactivity, whether these are achieved by

(1) direct killing by activated lymphocytes, (2) interaction with antibodies produced by

plasma cells, or (3) activation of macrophages by

lymphokines produced by T lymphocytes.

Page 55: PATHOLOGY

Persistent tissue destruction, with damage to both parenchymal cells and stromal framework, is a hallmark of chronic inflammation.

As a consequence, repair cannot be accomplished solely by regeneration of parenchymal cells, even in organs whose cells are able to regenerate.

Attempts at repairing tissue damage then occur by replacement of non-regenerated parenchymal cells by connective tissue, which in time produces fibrosis and scarring.

The process is granulation tissue and is fundamentally similar to that occurring in the healing of wounds, but because the injury is persistent, and the inflammatory reaction ebbs and flows, the events are less predictable.

Page 56: PATHOLOGY

Granulation Tissue

Formation of new blood vessels (angiogenesis)

Migration and proliferation of fibroblasts Deposition of extracellular matrix Maturation and organization of the fibrous

tissue, also known as remodeling.

Page 57: PATHOLOGY
Page 58: PATHOLOGY
Page 59: PATHOLOGY
Page 60: PATHOLOGY

Granulation Tissue

The process of repair begins early in inflammation.

Sometimes as early as 24 hours after injury, fibroblasts and vascular endothelial cells being proliferating to form (by 3 to 5 days) the specialized type of tissue (granulation tissue) that is the hallmark of healing.

Page 61: PATHOLOGY

The term granulation tissue derives from its pink, soft, granular appearance on the surface of wounds, but it is the histologic features that are characteristic: The proliferation of new small blood vessels

New vessels originate by budding or sprouting of pre-existing vessels, a process called angiogenesis or neovascularization.

The proliferation of fibroblasts.

Page 62: PATHOLOGY

Several factors can induce angiogenesis, notably basic fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF or vascular permeability factor [VPF ]).

Migration of fibroblasts to the site of injury and their subsequent proliferation are undoubtedly triggered by growth factors, such as PDGF, EGF, FGF, and TGF-b, and the

fibrogenic cytokines, derived in part from inflammatory macrophages.

Some of these growth factors also stimulate synthesis of collagen and other connective tissue molecules.

Page 63: PATHOLOGY

These new vessels have leaky interendothelial junctions, allowing the passage of proteins and red cells into the extravascular space.

Thus, new granulation tissue is often edematous.

Page 64: PATHOLOGY

ACUTEACUTE CHRONICCHRONIC

Vascular changesVascular changes

Cellular infiltratesCellular infiltrates

StromalStromal changeschanges

Vasodilation andIncreased permeability

Polymorphs

Minimal -separation dueto edema

Minimal

Mononuclear

Cellular proliferationFibrosis

Characteristics of acute and chronic inflammation

Page 65: PATHOLOGY

InflammationAcute vs. Chronic Inflammation

Acute inflammationAccumulation of fluid and plasma components in

the affected tissue Intravascular stimulation of plateletsPresence of polymorphonuclear leukocytes

(PMNs) Chronic inflammation

Lymphocytes, plasma cells, and macrophages

Page 66: PATHOLOGY

MIXED ACUTE & CHRONIC INFLAMMATION Because acute and chronic inflammation

represent different types of host response to injury, features of both types of inflammation may coexist in certain circumstances, as in chronic suppurative inflammation and recurring acute inflammation.

Page 67: PATHOLOGY

Chronic Suppurative Inflammation

The surrounding viable tissue responds with a longstanding inflammatory process in which areas of suppuration (liquefied necrotic tissue and neutrophils) alternate with areas of chronic inflammation (lymphocytes, plasma cells, macrophages) and fibrosis.

Such a pattern occurs in chronic suppurative osteomyelitis and pyelonephritis.

If the area of suppuration localizes to an abscess that remains over a long period, a fibrous wall of increasing thickness forms.

The difference between an acute and a chronic abscess lies in the thickness of the fibrous wall; both forms are filled with pus.

Page 68: PATHOLOGY

"chronic abscess" with elements of both acute and chronic inflammation. Seen here in the right middle lung lobe is just such a chronic abscess.

Page 69: PATHOLOGY

Recurrent Acute Inflammation

Repeated attacks of acute inflammation may occur if there is a predisposing cause, eg, in the gallbladder when there are gallstones.

Each attack of acute inflammation is followed by incomplete resolution that leads to a progressively increasing number of chronic inflammatory cells and fibrosis.

Depending on the time of examination, the picture may be mainly that of chronic inflammation or of acute superimposed on chronic inflammation. The terms subacute inflammation and acute-on-chronic inflammation are also used to denote this pattern.

Page 70: PATHOLOGY

mixed inflammation is typical of repeated or recurrent inflammation

a diagnosis of "acute and chronic cholecystitis" or "acute and chronic cervicitis" can be made.

Page 71: PATHOLOGY

Morphologic Patterns

The severity of the reaction, its specific cause, and the particular tissue and site involved all introduce morphologic variations in the basic patterns of acute and chronic inflammation:

1. Serous inflammation 2. Fibrinous inflammation3. Suppurative or Purulent inflammation4. Necrotizing inflammation5. Hemorragic inflammation

Page 72: PATHOLOGY

1. Serous Inflammation

Serous inflammation is marked by the outpouring of a thin fluid that, depending on the size of injury, is derived from either the blood serum or the secretions of mesothelial cells lining the peritoneal, pleural, and pericardial cavities (called effusion).

The skin blister resulting from a burn or viral infection represents a large accumulation of serous fluid, either within or immediately beneath the epidermis of the skin.

Page 73: PATHOLOGY

Types of Serous Inflammation

Vesicle (blister): an elevation (<1 cm) of the epidermis containing watery liquid (herpes labialis).

Bulla (large blister): an elevation (>1 cm) of the epidermis containing watery liquid (bullous pemphigoid, sunburn).

Catarrh: inflammation of a mucous membrane (especially affecting the nose and air passages- rhinitis catarrhalis)

Page 74: PATHOLOGY
Page 75: PATHOLOGY
Page 76: PATHOLOGY

2. Fibrinous Inflammation With more severe injuries and the resulting

greater vascular permeability, larger molecules such as fibrin pass the vascular barrier.

A fibrinous exudate develops when the vascular leaks are large enough or there is a procoagulant stimulus in the interstitium (e.g., cancer cells).

A fibrinous exudate is characteristic of inflammation in body cavities, such as the pericardium and pleura.

Histologically, fibrin appears as an eosinophilic meshwork of threads, or sometimes as an amorphous coagulum.

Page 77: PATHOLOGY

Fibrinous exudates may be removed by fibrinolysis, and other debris by macrophages (resolution).

But when the fibrin is not removed it may stimulate the ingrowth of fibroblasts and blood vessels and thus lead to scarring. Conversion of the fibrinous exudate to scar

tissue (organization) within the pericardial sac will lead either to opaque fibrous thickening of the pericardium and epicardium in the area of exudation or, more often, to the development of fibrous strands that bridge the pericardial space.

Page 78: PATHOLOGY
Page 79: PATHOLOGY
Page 80: PATHOLOGY
Page 81: PATHOLOGY

3. Suppurative or Purulent Inflammation

This form of inflammation is characterized by the production of large amounts of pus or purulent exudate consisting of neutrophils, necrotic cells, and edema fluid.

Certain organisms (e.g., staphylococci) produce this localized suppuration and are therefore referred to as pyogenic (pus-producing) bacteria.

Page 82: PATHOLOGY
Page 83: PATHOLOGY

Abscess: focal localized collections of purulent inflammatory tissue caused by suppuration buried in a tissue, an organ, or a confined space (fruncle, dental abscess)

Phlegmon: a purulent inflammation and infiltration of connective tissue without collection (acute appendicitis)

Pustule: a small circumscribed elevation of the skin containing pus and having an inflamed base (subcorneal pustular dermatosis)

Empyema: the presence of pus in a body cavity (as the pleural cavity; called also pyothorax).

Page 84: PATHOLOGY

Abscesses are produced by deep seeding of pyogenic bacteria into a tissue.

An abscess has a central region that appears as a mass of necrotic white cells and tissue cells.

There is usually a zone of preserved neutrophils about this necrotic focus, and outside this region vascular dilatation and parenchymal and fibroblastic proliferation occur, indicating the beginning of repair (pyogenic membrane).

In time, the abscess may become walled off by connective tissue that limits further spread.

Page 85: PATHOLOGY
Page 86: PATHOLOGY
Page 87: PATHOLOGY
Page 88: PATHOLOGY
Page 89: PATHOLOGY
Page 90: PATHOLOGY

4. Necrotizing inflammation

An ulcer is a local defect, or excavation, of the surface of an organ or tissue that is produced by the sloughing (shedding) of inflammatory necrotic tissue.

Ulceration can occur only when an inflammatory necrotic area exists on or near the surface. It is most commonly encountered in (1) inflammatory necrosis of the mucosa of the mouth,

stomach, intestines, or genitourinary tract, and (2) subcutaneous inflammations of the lower extremities

in older persons and diabetics who have circulatory disturbances that predispose to extensive necrosis.

Page 91: PATHOLOGY

Ulcerations are best exemplified by the peptic ulcer of the stomach or duodenum.

During the acute stage, there is intense polymorphonuclear infiltration and vascular dilatation in the margins of the defect.

With chronicity, the margins and base of the ulcer develop fibroblastic proliferation, scarring, and the accumulation of lymphocytes, macrophages, and plasma cells.

Page 92: PATHOLOGY
Page 93: PATHOLOGY
Page 94: PATHOLOGY

A Cavern is a hollow defect within a solid organ, which is produced by the sloughing of inflammatory necrotic tissue.

It is most commonly encountered in Cavitaty tuberculosis due to the Caseous necrosis.

Page 95: PATHOLOGY
Page 96: PATHOLOGY

Pus is either an exudate or an area of liquefaction necrosis containing neutrophilic leukocytes and necrotic debris.

The preferred adjective to describe things with lots of pus is purulent.

To produce pus is to suppurate. Pus which literally fills an important body

cavity is called an empyema. Color of pus:

Pus always has a yellow-green tinge because of myeloperoxidase.

Classic yellow pus (as in a staphylococcal boil) also includes some lipid from necrotic tissue.

Pseudomonas bacteria make a dye which imparts a blue-green fluorescence to pus.

Page 97: PATHOLOGY

InflammationSystemic Manifestations of Inflammation

• Fever - clinical hallmark of inflammation• Endogenous pyrogens: IL-1 and TNF-

• Leukocytosis - may be neutrophils, eosinophils, or lymphocytes

• Leukopenia - rare• Acute Phase Reactants - non-specific

elevation of many serum proteins - will markedly increase the “red-cells sedimentation rate (ESR)”

Page 98: PATHOLOGY

Leukocytosis and Leukopenia Mediators increased production and

early release of neutrophils from the bone marrow Increased neutrophils in the blood stream Leukocytosis, the presence of young neutrophils is called a

left shift.  Bone marrow inhibition Leukopenia

viral infections, unusual bacterial infections (typhoid,

rickettsial disease).

Page 99: PATHOLOGY
Page 100: PATHOLOGY

InflammationSystemic Manifestations of Inflammation

• Shock – most common in Gram-negative septicemia (bacteria in the bloodstream), although it can occur with Gram-positive bacteremia• Lipopolysaccharide (LPS or endotoxin) of

Gram-negatives can produce symptoms of shock when injected into animals

• TNF-can produce a similar syndrome.

Page 101: PATHOLOGY

Complications and sequelae Acute inflammation

Serous inflammation Catarrh (asphyxia, diarrhea) Perifocal edema (brain)

Suppurative/purulent inflammation

Pyemia/septicemia Fistulization Empyema Pressure (brain)

Ulcer Perforation (stomach,

bowel) Bleeding (stomach, bowel) Stenosis (stomach, bowel).

Chronic inflammation Scar and Keloid Stenosis (heart valves,

GI, urinary, ect.) Failure (heart valves) Obstruction (urinary,

GI, biliary, respiratory, ect.)

Adhesion (periton, pleura)

Amyloidosis (kidney, liver, adrenal, spleen).

Page 102: PATHOLOGY